跳至主要内容
临床试验/NL-OMON37670
NL-OMON37670已完成不适用

Towards plannable breast surgery: diagnostic accuracy of microbubble enhanced Iodine-125 seed localization of the sentinel lymph node (MIB study) - Microbubbles and Iodine seeds in Breast cancer: MIB study

niversitair Medisch Centrum Utrecht0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational invasive

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Females, aged 18 years or older
  • - Histologically confirmed invasive carcinoma or patients with in situ breast cancer with indication for SLN biopsy

排除标准

  • - Male patients
  • - Histologically or cytologically proven axillary lymph node involvement
  • - Recurrent disease
  • - Indication for ALND
  • - Pregnancy or lactation
  • - Sentinel lymph node biopsy after neoadjuvant treatment
  • - Recent acute coronary syndrome or unstable ischemic heart disease*
  • - Severe lung disease* and shortness of breath
  • - Unstable neurologic disease, acute endocarditis, artificial heart valves, acute systemic infection, tromboembolic disease, advanced liver or kidney failure
  • - Mentally incompetent patients;* SonoVue is contraindicated in patients known to have right-to-left shunts, severe pulmonary hypertension (pulmonary artery pressure >90 mmHg, uncontrolled systemic hypertension, and in patients with adult respiratory distress syndrome. Caution is advised when SonoVue is administered to patients with clinically significant pulmonary disease, including severe chronic obstructive pulmonary disease.

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验